Somalogic Inc
F:76X0

Watchlist Manager
Somalogic Inc Logo
Somalogic Inc
F:76X0
Watchlist
Price: 1.93 EUR -3.5% Market Closed
Market Cap: 364.2m EUR

Operating Margin

-214%
Current
Declining
by 20.6%
vs 3-y average of -193.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-214%
=
Operating Income
$-149.7m
/
Revenue
$81.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-214%
=
Operating Income
€-149.7m
/
Revenue
$81.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Somalogic Inc
F:76X0
364.2m EUR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.5B USD
Loading...
US
Danaher Corp
NYSE:DHR
169.6B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.1B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
281.8B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.2T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.4B USD
Loading...
US
Waters Corp
NYSE:WAT
23.8B USD
Loading...

Market Distribution

Lower than 88% of companies in the United States of America
Percentile
12th
Based on 14 112 companies
12th percentile
-214%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Somalogic Inc
Glance View

SomaLogic, Inc. is a commercial-stage proteomics company, which built an integrated proteomics platform for robust, high throughput proteomics analysis, research and clinical applications. The company is headquartered in New York City, New York and currently employs 320 full-time employees. The company went IPO on 2021-02-23. The company develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein. The company offers SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. Its products include SomaScan Assay, SomaSignal Tests, SomaScan Panels, and SOMAmer Reagents. SomaScan Assay is utilized for Research Use Only (RUO) applications. Its SomaScan Assay measures approximately 7,000 protein target measurements in a single sample. SomaSignal Tests are available as laboratory developed tests (LDT) for use in obtaining proteomics information from patients and monitoring patients’ physiological states, among others. SomaScan Panels consists of two categories: fixed panels and custom panels. The company offers drug development, analysis of clinical trial and new human biology insights.

76X0 Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-214%
=
Operating Income
$-149.7m
/
Revenue
$81.7m
What is Somalogic Inc's current Operating Margin?

The current Operating Margin for Somalogic Inc is -214%, which is below its 3-year median of -193.4%.

How has Operating Margin changed over time?

Over the last 3 years, Somalogic Inc’s Operating Margin has decreased from -74.8% to -214%. During this period, it reached a low of -208.3% on Mar 31, 2023 and a high of -37.4% on Jun 30, 2021.

Back to Top